These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9528804)

  • 1. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
    Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ
    Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein.
    Rauh MJ; Blackmore V; Andrechek ER; Tortorice CG; Daly R; Lai VK; Pawson T; Cardiff RD; Siegel PM; Muller WJ
    Mol Cell Biol; 1999 Dec; 19(12):8169-79. PubMed ID: 10567542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.
    Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ
    Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
    Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
    Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
    Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen.
    Campbell KS; Ogris E; Burke B; Su W; Auger KR; Druker BJ; Schaffhausen BS; Roberts TM; Pallas DC
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6344-8. PubMed ID: 8022784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A.
    Mullane KP; Ratnofsky M; Culleré X; Schaffhausen B
    Mol Cell Biol; 1998 Dec; 18(12):7556-64. PubMed ID: 9819441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
    Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
    Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
    Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
    Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
    J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.
    Al Masri A; Gendler SJ
    Oncogene; 2005 Sep; 24(38):5799-808. PubMed ID: 15897873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of proline-rich domain in polyomavirus T antigens results in virus partially defective in transformation and tumorigenesis.
    Yi X; Freund R
    Virology; 1998 Sep; 248(2):420-31. PubMed ID: 9721249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct ErbB-2 coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles.
    Schade B; Lam SH; Cernea D; Sanguin-Gendreau V; Cardiff RD; Jung BL; Hallett M; Muller WJ
    Cancer Res; 2007 Aug; 67(16):7579-88. PubMed ID: 17699761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Gu H; Maeda H; Moon JJ; Lord JD; Yoakim M; Nelson BH; Neel BG
    Mol Cell Biol; 2000 Oct; 20(19):7109-20. PubMed ID: 10982827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTL1 family members.
    Webster MA; Martin-Soudant N; Nepveu A; Cardiff RD; Muller WJ
    Oncogene; 1998 Apr; 16(15):1963-72. PubMed ID: 9591780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
    Denis D; Rouleau C; Schaffhausen BS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.
    Walker F; Kato A; Gonez LJ; Hibbs ML; Pouliot N; Levitzki A; Burgess AW
    Mol Cell Biol; 1998 Dec; 18(12):7192-204. PubMed ID: 9819406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V; Scott RP; Ibáñez CF
    J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding.
    Yi X; Peterson J; Freund R
    J Virol; 1997 Sep; 71(9):6279-86. PubMed ID: 9261344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
    Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
    Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.